StockNews.AI
CMRX
StockNews.AI
167 days

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX and GLYC on Behalf of Shareholders

1. Chimerix to be sold to Jazz Pharmaceuticals for $8.55 per share. 2. Halper Sadeh LLC investigates potential shareholder rights violations concerning the sale. 3. Investors may seek increased purchase price or additional disclosures. 4. The law firm represents investors in recovering losses and fraud cases. 5. Chimerix shareholders encouraged to contact Halper Sadeh for legal options.

3m saved
Insight
Article

FAQ

Why Bearish?

The investigation indicates potential shareholder dissatisfaction with the sale price, possibly leading to selling pressure.

How important is it?

Increased focus on legal rights may impact investor sentiment and stock valuation.

Why Short Term?

Shareholder reactions and legal outcomes can quickly affect stock price leading up to the sale completion.

Related Companies

GLYC
NEW YORK, March 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Chimerix, Inc. (NASDAQ: CMRX)'s sale to Jazz Pharmaceuticals plc for $8.55 per share in cash. If you are a Chimerix shareholder, click here to learn more about your rights and options. GlycoMimetics, Inc. (NASDAQ: GLYC)'s merger with Crescent Biopharma, Inc. Upon closing of the proposed transaction, GlycoMimetics stockholders are expected to own approximately 3.1% of the combined company. If you are a GlycoMimetics shareholder, click here to learn more about your rights and options. Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected]. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information:Halper Sadeh LLCDaniel Sadeh, Esq.Zachary Halper, Esq.(212) 763-0060[email protected][email protected] https://www.halpersadeh.com SOURCE Halper Sadeh LLP

Related News